Go to deals
Healthcare

IceCure Medical has issued bonds worth US$5.7 million

IceCure Medical Ltd. has completed a fundraising to refinance and develop the company.

IceCure is an Israeli medical device company that has developed technology to eliminate benign and cancerous tumors in the breast and other parts of the body by freezing the tumor during treatment in a clinic and without surgery, using the ProSense system developed at the Elisha Private Hospital in Haifa.

Oaklins’ team in Israel advised IceCure Medical Ltd. and acted as the leader of the distributors’ consortium.

Service
Funding, debt advisory & ECM
Parties

Talk to the deal team

 Ruben  Eblagon

Ruben Eblagon

Principal

Tel Aviv, Israel
Oaklins Rosario
 Boaz  Levi

Boaz Levi

Partner

Tel Aviv, Israel
Oaklins Rosario

Related deals

Intergrin has raised financing provided by Kartesia
Healthcare

Intergrin has raised financing provided by Kartesia

Intergrin has obtained a unitranche loan of approximately US$59 million to refinance existing debt and to further support the growth of different healthcare and well-being initiatives.

Learn more
MediCA klinika acquires G. Radavičiaus klinika
Healthcare

MediCA klinika acquires G. Radavičiaus klinika

MediCA klinika has acquired G. Radavičiaus klinika.

Learn more
Nutricare has raised US$3.1 million via an entitlement offer
Consumer & Retail | Healthcare

Nutricare has raised US$3.1 million via an entitlement offer

Nutricare Pty Ltd has raised funds to support its growth strategy.

Learn more